Form D · Pharmaceuticals
Hoverink Biotechnologies, Inc.
Los Angeles, CA · CIK 0001586494
Offering snapshot reported Jan 30, 2020 · SEC filing
- Reported sold
- Yet to sell Offering amount: $8.39M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 30, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 1, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 3, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 24, 2019 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jan 8, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 12, 2018 | Amendment | Yet to sell | No comparison | 1 | SEC filing |
| Mar 5, 2018 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Mar 5, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 4, 2017 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Oct 3, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 19, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-359414
Common Stock
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Jan 30, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Debbie Mae Carter | Director, Executive |
| Debbie Carter | Director, Executive |
| Cyrus Sajna | Director, Executive |
| Davidra Nicole Sajna | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1801 Century Park East 24 Th Floor
Los Angeles, CA, 90067
Los Angeles, CA, 90067